{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:07:13Z","timestamp":1790262433879,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ncl.2011.05.009","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T13:15:19Z","timestamp":1311945319000},"page":"679-687","source":"Crossref","is-referenced-by-count":16,"title":["Emerging Toxic Neuropathies and Myopathies"],"prefix":"10.1016","volume":"29","author":[{"given":"Hani A.","family":"Kushlaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2011.05.009_bib1","unstructured":"Stagniti MN. Trends in statins utilization and expenditure for the U.S. civilian noninstitutionalized population, 2000 and 2005. Agency for Healthcare Research and Quality. Statistical brief #205, May 2008."},{"key":"10.1016\/j.ncl.2011.05.009_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/WCO.0b013e32833c2054","article-title":"Iatrogenic myopathies","volume":"23","author":"Mastalgia","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ncl.2011.05.009_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2014a genome wide study","volume":"359","author":"Link","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2011.05.009_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/01.md.0000209337.59874.aa","article-title":"Statin-associated myasthenia gravis: report of 4 cases and review of the literature","volume":"85","author":"Purvin","year":"2006","journal-title":"Medicine"},{"key":"10.1016\/j.ncl.2011.05.009_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/mus.20575","article-title":"Sporadic rippling muscle disease unmasked by simvastatin","volume":"34","author":"Baker","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2011.05.009_bib6","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.0b013e31820c3648","article-title":"Myopathy: five new things","volume":"76","author":"Oskarsson","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.05.009_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2008.05.021","article-title":"Molecular basis of statin-associated myopathy","volume":"202","author":"Vaklavas","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ncl.2011.05.009_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ajhg.2008.09.002","article-title":"Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood","volume":"83","author":"Zeharia","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2011.05.009_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2265.2008.03448.x","article-title":"Vitamin D insufficiency\u2014a novel mechanism of statin-induced myalgia?","volume":"71","author":"Lee","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ncl.2011.05.009_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2011.05.009_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1345\/aph.1K604","article-title":"Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance","volume":"42","author":"Backes","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ncl.2011.05.009_bib12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","article-title":"Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance","volume":"80","author":"Neuvonen","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ncl.2011.05.009_bib13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archinte.153.9.1079","article-title":"Lovastatin 5-year safety and efficacy study","volume":"153","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ncl.2011.05.009_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.58.9.1333","article-title":"Statins and risk of polyneuropathy: a case-control study","volume":"58","author":"Gaist","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.05.009_bib15","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1056\/NEJMc0708896","article-title":"Imatinib as a possible cause of rhabdomyolysis","volume":"358","author":"Penel","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2011.05.009_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.leukres.2009.11.002","article-title":"Elevations of creatine kinase in patients treated with imatinib mesylate","volume":"34","author":"Gordon","year":"2010","journal-title":"Leuk Res"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2011.05.009_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1469-0691.2006.01342.x","article-title":"The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria","volume":"12","author":"Rybak","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ncl.2011.05.009_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/mus.21691","article-title":"Characterization of skeletal muscle effects associated with daptomycin in rats","volume":"42","author":"Kostrominova","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2011.05.009_bib19","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/mus.21091","article-title":"Severe hydroxychloroquine myopathy","volume":"38","author":"Abdel-Hamid","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2011.05.009_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.0b013e3181aae814","article-title":"Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy","volume":"73","author":"Pfeffer","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.05.009_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.0b013e3182074a69","article-title":"Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome","volume":"76","author":"Lehky","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.05.009_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1529-8027.2008.00193.x","article-title":"Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy","volume":"13","author":"Chaudhry","year":"2008","journal-title":"J\u00a0Peripher Nerv Syst"},{"key":"10.1016\/j.ncl.2011.05.009_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1529-8027.2010.00287.x","article-title":"Bortezomib-induced inflammatory neuropathy","volume":"15","author":"Saifee","year":"2010","journal-title":"J\u00a0Peripher Nerv Syst"},{"key":"10.1016\/j.ncl.2011.05.009_bib24","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.bjc.6605954","article-title":"Schwann cell autophagy induced by SAHA, 17 AAG, or clonazepam can reduce bortezomib-induced peripheral neuropathy","volume":"103","author":"Watanabe","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ncl.2011.05.009_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.pediatrneurol.2010.05.019","article-title":"An unusual cause of fulminant Guillain-Barr\u00e9 syndrome: angel\u2019s trumpet","volume":"43","author":"Sevketoglu","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ncl.2011.05.009_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/15563650701378720","article-title":"Unilateral mydriasis due to angel\u2019s trumpet","volume":"46","author":"Andriol","year":"2008","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ncl.2011.05.009_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00001813-199506000-00003","article-title":"Cisplatin-associated neurotoxicity: can it be prevented?","volume":"6","author":"Alberts","year":"1995","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ncl.2011.05.009_bib28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.0b013e3181d5279e","article-title":"Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial","volume":"74","author":"Pace","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.05.009_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mus.10559","article-title":"Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy","volume":"29","author":"Lehky","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2011.05.009_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/1471-2407-10-451","article-title":"Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve Hyperexcitability","volume":"10","author":"Hill","year":"2010","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ncl.2011.05.009_bib31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2010-0248","article-title":"Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility","volume":"16","author":"Park","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.ncl.2011.05.009_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2010.10.014","article-title":"Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity","volume":"301","author":"Venneti","year":"2011","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2011.05.009_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy","volume":"37","author":"St\u00fcbgen","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2011.05.009_bib34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/mus.21584","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with TNF-\u03b1 antagonists","volume":"41","author":"Alshekhlee","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2011.05.009_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mus.21638","article-title":"Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement","volume":"42","author":"Ikeda","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2011.05.009_bib36","doi-asserted-by":"crossref","first-page":"825.e15","DOI":"10.1016\/j.arth.2008.07.017","article-title":"Severe cobalt intoxication due to prosthesis wear in repeated total hip arthroplasty","volume":"24","author":"Oldenburg","year":"2009","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.ncl.2011.05.009_bib37","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1212\/01.wnl.0000312375.79881.94","article-title":"Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease","volume":"71","author":"Nations","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2011.05.009_bib38","first-page":"1012","article-title":"Myelo-opticoneuropathy in copper deficiency occurring after partial gastrectomy: do small bowel bacterial overgrowth syndrome and occult zinc ingestion tip the balance?","volume":"254","author":"Spinazzi","year":"2007","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2011.05.009_bib39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1634\/theoncologist.2008-0284","article-title":"Proactive management of adverse events maintains the clinical benefit of ixabepilone","volume":"14","author":"Yardley","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.ncl.2011.05.009_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(09)70296-0","article-title":"An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolized porcine neural tissue: a descriptive study","volume":"9","author":"Lachance","year":"2010","journal-title":"Lancet Neurol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861911000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861911000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T04:16:56Z","timestamp":1638159416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861911000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0733861911000430"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2011.05.009","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}